Skip to main content
. 2022 Jan 7;12:91. doi: 10.1038/s41598-021-04032-x

Table 6.

Changes in intrinsic subtype after neoadjuvant chemotherapy. Differences between pre- and post-chemotherapy assessments were not statistically significant.

Subtype post-chemotherapy Total
HER2+ Luminal A Luminal B HER2− Luminal B HER2+ Triple negative
Subtype pre-chemotherapy
 HER2+ 18 1 1 1 0 21
 Luminal A 0 36 12 0 0 48
 Luminal B HER2− 0 4 24 1 1 30
 Luminal B HER2+ 0 2 3 20 0 25
 Triple Negative 0 2 0 0 32 34
Total 18 45 40 22 33 158